Score Overview
See the full market ranking โ
Puma Biotechnology Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 225M to $ 228M and net income went from -$ 59M to $ 31M. Revenue increased in 2 of those 5 years; net income in 4.
Puma Biotechnology Inc currently holds a 5-year HDB Score of 6.4 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 8.90 | โ |
1 Year2025-08-12 | $ 4.87 | 82.75% |
5 Years2021-08-12 | $ 7.28 | 22.25% |
10 Years2016-08-12 | $ 48.63 | -81.70% |
All Time2012-04-24 | $ 14.00 | -36.43% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2012-04-24 |
|---|---|---|---|---|---|
| Price | $ 8.90 | $ 4.87 | $ 7.28 | $ 48.63 | $ 14.00 |
| Return | โ | 82.75% | 22.25% | -81.70% | -36.43% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 231M | $ 26M | $ 93M |
| 2025 | $ 228M | $ 31M | $ 97M |
| 2024 | $ 230M | $ 30M | $ 100M |
| 2023 | $ 235M | $ 21M | $ 95M |
| 2022 | $ 228M | $ 2K | $ 81M |
| 2021 | $ 253M | -$ 29M | $ 82M |
| 2020 | $ 225M | -$ 59M | $ 93M |
| 2019 | $ 272M | -$ 75M | $ 111M |
| 2018 | $ 251M | -$ 113M | $ 108M |
| 2017 | $ 27M | -$ 292M | $ 81M |
| 2016 | $ 0.00 | -$ 276M | $ 194M |
| 2015 | $ 0.00 | -$ 239M | $ 31M |
| 2014 | $ 0.00 | -$ 142M | $ 38M |
| 2013 | $ 0.00 | -$ 54M | $ 83M |
| IPO2012 | $ 0.00 | -$ 74M | $ 137M |
Explore beyond PBYI
You're looking at Puma Biotechnology Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score โ 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
